Bernstein Elana J, Gordon Jessica K, Spiera Robert F, Huang Wei-Ti, Horn Evelyn M, Mandl Lisa A
Division of Rheumatology, Department of Medicine, Columbia University College of Physicians and Surgeons, New York-Presbyterian Hospital
Division of Rheumatology, Department of Medicine, Hospital for Special Surgery.
Rheumatology (Oxford). 2017 Jan;56(1):87-94. doi: 10.1093/rheumatology/kew365. Epub 2016 Oct 25.
Pulmonary hypertension (PH) is an important cause of morbidity and mortality in patients with SSc. The submaximal heart and pulmonary evaluation (step test) is a non-invasive, submaximal stress test that could be used to identify SSc patients with PH. Our aims were to determine whether change in end tidal carbon dioxide ([Formula: see text]) from rest to end-exercise, and the minute ventilation to carbon dioxide production ratio ([Formula: see text]), both as measured by the step test, differ between SSc patients with and without PH. We also examined differences in validated self-report questionnaires and potential PH biomarkers between SSc patients with and without PH.
We performed a cross-sectional study of 27 patients with limited or dcSSc who underwent a right heart catheterization within 24 months prior to study entry. The study visit consisted of questionnaire completion; history; physical examination; step test performance; and phlebotomy. [Formula: see text], [Formula: see text], self-report data and biomarkers were compared between patients with and without PH.
SSc patients with PH had a statistically significantly lower median (interquartile range) [Formula: see text] than SSc patients without PH [-2.1 (-5.1 to 0.7) vs 1.2 (-0.7 to 5.4) mmHg, P = 0.035], and a statistically significantly higher median (interquartile range) [Formula: see text] [53.4 (39-64.1) vs 36.4 (31.9-41.1), P = 0.035]. There were no statistically significant differences in self-report data or biomarkers between groups.
[Formula: see text] and [Formula: see text] as measured by the step test are statistically significantly different between SSc patients with and without PH. [Formula: see text] and [Formula: see text] may be useful screening tools for PH in the SSc population.
肺动脉高压(PH)是系统性硬化症(SSc)患者发病和死亡的重要原因。次极量心肺评估(阶梯试验)是一种非侵入性的次极量应激试验,可用于识别患有PH的SSc患者。我们的目的是确定通过阶梯试验测量的静息至运动结束时呼末二氧化碳([公式:见正文])的变化以及分钟通气量与二氧化碳产生率([公式:见正文])在有和没有PH的SSc患者之间是否存在差异。我们还研究了经过验证的自我报告问卷以及有和没有PH的SSc患者之间潜在的PH生物标志物的差异。
我们对27例局限性或弥漫性皮肤型SSc患者进行了横断面研究,这些患者在研究入组前24个月内接受了右心导管检查。研究访视包括问卷填写、病史采集、体格检查、阶梯试验以及静脉穿刺采血。比较了有和没有PH的患者之间的[公式:见正文]、[公式:见正文]、自我报告数据和生物标志物。
患有PH的SSc患者的中位数(四分位间距)[公式:见正文]在统计学上显著低于没有PH的SSc患者[-2.1(-5.1至0.7)mmHg对1.2(-0.7至5.4)mmHg,P = 0.035],并且中位数(四分位间距)[公式:见正文]在统计学上显著更高[53.4(39 - 64.1)对36.4(31.9 - 41.1),P = 0.035]。两组之间的自我报告数据或生物标志物没有统计学上的显著差异。
通过阶梯试验测量的[公式:见正文]和[公式:见正文]在有和没有PH的SSc患者之间在统计学上有显著差异。[公式:见正文]和[公式:见正文]可能是SSc人群中PH的有用筛查工具。